Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2003
06/18/2003EP1319070A2 Mammalian receptor genes and uses
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319064A2 Gsk3 polypeptides
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319010A1 Tricyclic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (mmp) inhibitors
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319002A1 Alpha v integrin receptor antagonists
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003EP1318825A2 Plant extract
06/18/2003EP1318819A1 Treatment of trauma, and other indications
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1318801A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0868177B1 Drug delivery device
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424908A Patch containing anti-inflammatory agent
06/18/2003CN1424105A Medicinal spray
06/18/2003CN1424101A Chinese medicines for treating dymenorrhea
06/18/2003CN1424095A Analgestic plaster
06/18/2003CN1424094A Detumescence plaster
06/18/2003CN1424087A Wind damp and cold pain powder
06/18/2003CN1424070A Plaster
06/18/2003CN1424054A Bacterial Chinese medical preparation and preparing method thereof
06/18/2003CN1424051A Lyophilized scorpion venoms powder injection
06/18/2003CN1424049A Oral medicine for mastadenitis and mammary pains and preparing method thereof
06/18/2003CN1424044A Gene medicine against mammitis of dairy cow
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/18/2003CN1111423C Medicine for treating injury
06/18/2003CN1111415C Medicine for hyperosteogeny and protrusion of intervertebral disc
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/18/2003CN1111402C Tramadol multiple unit formulations
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6580249 Intelligent serial battery charger and charging block
06/17/2003US6579989 Sulphostin analogue and process for producing sulphostin and its analogue
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579895 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579864 Arthritic diseases and/or autoimmune diseases
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003US6579684 Assay of YKL-40 as a marker for cancer
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048152A2 Inflammation modulators
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048139A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholipase of group ii
06/12/2003WO2003048137A1 Metabotropic glutamate receptor-5 modulators
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047612A1 The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders
06/12/2003WO2003047604A1 Use of selenite-containing compounds to be topically or buccally administered
06/12/2003WO2003047598A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047588A1 Kit for reducing aching caused by pde-v inhibitors
06/12/2003WO2003047578A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist
06/12/2003WO2003047561A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
06/12/2003WO2003047524A2 Methods and compositions for modulating the immune system and uses thereof
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003WO2003047420A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 1272